(Q34451927)

English

VEGF antagonists

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

VEGF antagonists (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Hasan J

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jayson GC

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

703-718

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Structural analysis of receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Role of vascular permeability factor/vascular endothelial growth factor in eye disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Identification of substituted 3-[(4,5,6, 7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rbeta tyrosine kinases

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.703

21 January 2018

Identifiers

10.1517/14712598.1.4.703

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

release_v4fmjc6blzdm3mwu26pb27p5hm

1 reference

https://api.fatcat.wiki/v0/release/v4fmjc6blzdm3mwu26pb27p5hm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34451927&oldid=2039655132"